NKGN (NKGen Biotech Corp) Bozor qiymatining balans qiymatiga nisbati

Hujayra terapiyalarini ishlab chiqish bilan bog'liq yuqori xarajatlar moliyaviy tebranishlarni keltirib chiqaradi, buni narxning buxgalteriya qiymatiga nisbati (P/B) ko'rsatkichi bilan isbotlash mumkin, u hozirda -0.07 atrofida saqlanmoqda. NKGen Biotech, Inc. (NKGN) o'z platformasini Altsgeymer va Parkinson kasalliklariga qarshi sinovdan o'tkazish orqali risklarni kamaytirmoqda. Ushbu ishlanmalarning innovatsion tabiati aktivga himoya xususiyatlarini beradi, chunki neyromeditsinaga bo'lgan talab makroiqtisodiy sharoitlardan mustaqil qolmoqda.

NKGN - nkgenbiotech.com Bozor qiymatining balans qiymatiga koeffitsiyenti 21.02.2024 - 15.03.2025 oraligʻida

NKGen Biotech Inc (NKGN) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi NKGen Biotech, Inc.|NKGN - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati NKGen|NKGN - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati NKGen Biotech|NKGN - Kompaniyaning xususiy kapitali|Kapitallashuvning sof aktivlarga nisbati nkgenbiotech.com|NKGN - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati NKGen Biotech, Inc.|NKGN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati NKGen|NKGN - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati NKGen|NKGN - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzi NKGen Biotech
Fundamental baholash:NKGN, NKGen Biotech, Inc.

Ushbu ko'rsatkich biznesning haqiqiy sof aktivlariga nisbatan haddan tashqari qimmat baholanganlik darajasini aniqlaydi. Bozor baholovchisi va aktivlarning balans qiymati nisbatini tahlil qilish orqali investor birja narxi va buxgalteriya qiymati o'rtasidagi farqni aniqlaydi. Ushbu metrika bozor kapitalizatsiyasining kompaniya kapitaliga nisbati sifatida hisoblanadi. NKGen Biotech, Inc. (NKGN) uchun ushbu farq bozorning spekulyativ kutganlarini aks ettiradi. Eksperimental terapiya va ishlab chiqarish xarajatlari bilan bog'liq yuqori xatarlar bunday tebranishlarni kritik darajaga olib keladi.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Biogen Inc.|NBIX (neurocrine.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|BHVN (Biohaven Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals (AMLX)|Kapitallashuvning balans qiymatiga nisbati TRVI|Bozor qiymatining balans qiymatiga nisbati PRAX|Bozor kapitallashuvining balans qiymatiga nisbati Anavex (AVXL)|CBLL (CeriBell Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Prothena PRTA|ALEC (Alector Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati omeros.com|Kapitallashuvning balans qiymatiga nisbati Neurogene Inc|ACIU - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Voyager Corp|Bozor kapitallashuvining balans qiymatiga nisbati Neumora Therapeutics (NMRA)|Bozor qiymatining balans qiymatiga nisbati scilexholding.com (SCLX)|Bozor kapitallashuvining balans qiymatiga nisbati TVGN|Alpha Cognition Inc - Balans qiymatiga nisbatan bozor kapitallashuvi|CGTX (Cognition Therapeutics, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Inhibikase Pharma (IKT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SAVA - Kapitallashuvning sof aktivlarga nisbati|Assertio (ASRT) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati COYA (Coya Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti VistaGen Therapeutics Inc|Bozor kapitallashuvining balans qiymatiga nisbati OVID (Ovid Therapeutics Inc.)|Kapitallashuvning sof aktivlarga nisbati Acumen Pharmaceuticals, Inc (ABOS)|Bozor kapitallashuvining balans qiymatiga nisbati CervoMed Inc.|ATHE - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Clene Nanomedicine (CLNN)|PEPG - Balans qiymatiga nisbatan bozor qiymati|Jupiter Neurosciences - Bozor kapitallashuvining balans qiymatiga nisbati|RLMD (Relmada Corp) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Annovis Bio, Inc. (ANVS)|Kapitallashuvning balans qiymatiga nisbati Grace Tx|Bozor kapitallashuvining balans qiymatiga nisbati AIFF (Firefly Neuroscience)|Kapitallashuvning sof aktivlarga nisbati anewmeds.com KLTO|Kapitallashuvning sof aktivlarga nisbati NRSN|Reviva Pharmaceuticals, Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi|MetaVia, Inc. (MTVA) - Bozor qiymatining balans qiymatiga nisbati|NRXS: Kapitallashuvning balans qiymatiga nisbati|HSDT: Bozor qiymatining balans qiymatiga nisbati|Passage Bio (PASG) - Bozor kapitallashuvining balans qiymatiga nisbati|Neuphoria Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati NERV|Bozor qiymatining balans qiymatiga nisbati Athira Pharma, Inc. ATHA|Kapitallashuvning balans qiymatiga nisbati ADXN (addextherapeutics.com)|ALZN - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Cyclerion Therapeutics Inc. CYCN|PTIX (Protagenic) - Bozor kapitallashuvining balans qiymatiga nisbati|Pasithea Therapeutics (KTTA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CRGT: Kapitallashuvning sof aktivlarga nisbati|ATXI (avenuetx.com) - Bozor kapitallashuvining balans qiymatiga nisbati|BCLI - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CARA|Chromocell Therapeutics Corporation - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ELYM (eliemtx.com)|ITCI - Bozor qiymatining balans qiymatiga nisbati|longboardpharma.com - Kapitallashuvning balans qiymatiga nisbati|Marinus Pharmaceuticals, Inc. - Bozor qiymatining balans qiymatiga nisbati|NRBO - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SAGE (Sage Therapeutics, Inc)|Synaptogenix, Inc (SNPX) - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TRVN (Trevena, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti VIGL|Bozor qiymatining balans qiymatiga nisbati Anew Medical, Inc. WENA|Kapitallashuvning balans qiymatiga nisbati Cerevel Therapeutics Inc CERE